Hattersley 1 , M.N
The SURMOUNT-5 trial, published in the New England Journal of Medicine, compared tirzepatide directly against semaglutide in people with obesity
If your protocol involves multiple peptides simultaneously , aliquoting becomes even more important
The molecular weight (MW) of Compound 1 is 507.56 g/mol, exceeding the 500 g/mol threshold of Lipinskis rules, suggesting potential synthetic challenges (Daina et al., 2017)
Some patients find that morning injections allow the highest concentration to hit during waking hours, slightly mitigating the severe nocturnal neurochemical disruptions
The astute reader may have noticed that a lot of these past studies were conducted using GLP1R agonists with much shorter half-lives (GLP1 = 5 minutes, Exenatide = 2 hours, Liraglutide = 13 hours)